Assessment of cell-free DNA (cfDNA) concentrations in the perioperative period can predict risk of recurrence in patients with non-metastatic breast cancer
- Resource Type
- Article
- Source
- In
Surgical Oncology June 2022 42 - Subject
- Language
- ISSN
- 0960-7404